Key result
Obstructive sleep apnoea affects ~37% of patients with diabetes, including ~10% with type 1.
Cross-Sectional (n=556)
Yes
Answers are grounded in this paper and cite their sources.
BACKGROUND: Diabetes and obstructive sleep apnoea (OSA) syndrome share a high prevalence in industrialized nations. The presence of OSA seems to promote the development of diabetes mellitus (DM) and vice versa. MATERIALS AND METHODS: In order to assess the prevalence of sleep disordered breathing, we studied 498 patients with DM type 2 and 58 patients with DM type 1 from 15 centres, using a screening device determining airflow and pulse oximetry. Age of the patients was 59.9 ± 13.1 years, mean body mass index was 31.9 ± 6.9 kg/m(2) . Duration of diagnosis of DM was 9.3 ± 7.3 years. RESULTS: Among the patients, 37.4% had an apnoea-hypopnoea index (AHI) ≥15/h suggestive of OSA. The prevalence of an AHI ≥ 15/h among the patients with DM type 1 was 10.3%. One hundred ninety-three (35.2%) patients suffered from neuropathy. We found a higher prevalence for neuropathy, nephropathy, hypertension, cardiovascular disease and heart failure in the group with an AHI ≥ 15/h. CONCLUSIONS: The prevalence of sleep disordered breathing is increased in patients with DM. Most of these patients had no typical clinical symptoms of OSA and would have been undiagnosed without diagnostic assessment of OSA.
No takes yet. Share an insight, caveat, or question.
Schober et al. (2010) conducted a cross-sectional in Diabetes mellitus (type 1 and type 2) and obstructive sleep apnoea (n=556). Diabetes mellitus (screened with airflow and pulse oximetry) was evaluated on Prevalence of obstructive sleep apnoea (apnoea-hypopnoea index [AHI] ≥15/h). Patients with diabetes mellitus had a 37.4% overall prevalence of obstructive sleep apnoea (AHI ≥15/h), including 10.3% among those with type 1 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: